Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: Identification of TUBB2A by quantitative proteomic analysis as a novel biomarker for the prediction of distant metastatic breast cancer

Fig. 1

Schematic of overall proteomic results of the TMT-based proteomic analysis. Number of identified proteins; pooled sample set: 9441, individual sample set: 8746, and cell line set: 7823. Number of DEPs by statistical analysis and the steps for selection of protein targets. Validation phase of protein targets; real-time polymerase chain reaction (RT-PCR) and migration/invasion assay

Back to article page

Clinical Proteomics

ISSN: 1559-0275